Xingyun Liao
Overview
Explore the profile of Xingyun Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng L, Zhang L, Li L, Liao X, Yin C, Zhang L, et al.
PeerJ
. 2024 Sep;
12:e18159.
PMID: 39346064
Recent breakthrough therapies have improved survival rates in non-small cell lung cancer (NSCLC), but a paradigm for prospective confirmation is still lacking. Patientdatasets were mainly downloaded from TCGA, CPTAC and...
2.
Zeng X, Wang T, Tang Y, Liao X, Wang J, Li Y
Curr Cancer Drug Targets
. 2024 Jul;
PMID: 38982693
Introduction: Icotinib and almonertinib are efficacious for non-small cell lung cancer (NSCLC) factor patients with epidermal growth receptor (EGFR)-mutation. Patients who previously used EGFR tyrosine kinase inhibitor (EGFR TKI) may...
3.
Liu J, Liao X, Li N, Xu Z, Yang W, Zhou H, et al.
MedComm (2020)
. 2024 Apr;
5(4):e534.
PMID: 38585235
Autoimmune uveitis (AU) is a kind of immune-mediated disease resulting in irreversible ocular damage and even permanent vision loss. However, the precise mechanism underlying dynamic immune changes contributing to disease...
4.
Zeng L, Li L, Liao X, Zhang L, Yin C, Chen X, et al.
Med Oncol
. 2024 Jan;
41(2):42.
PMID: 38170412
In lung squamous cell carcinoma (LUSC), current cancer vaccines show promising effects, despite a lack of benefit for a large number of patients. We first identified the tumor antigens into...
5.
Liu X, Meng J, Liao X, Liu Y, Zhou Q, Xu Z, et al.
Cell Mol Immunol
. 2023 Oct;
20(11):1379-1392.
PMID: 37828081
Vogt-Koyanagi-Harada (VKH) disease is a leading cause of blindness in young and middle-aged people. However, the etiology of VKH disease remains unclear. Here, we performed the first trio-based whole-exome sequencing...
6.
Li R, Liu J, Yi P, Yang X, Chen J, Zhao C, et al.
Adv Sci (Weinh)
. 2023 Apr;
10(16):e2206623.
PMID: 37017569
The underlying mechanisms that determine gene expression and chromatin accessibility in retinogenesis are poorly understood. Herein, single-cell RNA sequencing and single-cell assay for transposase-accessible chromatin sequencing are performed on human...
7.
Xu Z, Liao X, Li N, Zhou H, Li H, Zhang Q, et al.
Front Cell Dev Biol
. 2022 Jan;
9:802457.
PMID: 34977041
Human retinal pigment epithelium cells are arranged in a monolayer that plays an important supporting role in the retina. Although the heterogeneity of specific retinal cells has been well studied,...
8.
Zhou H, Xu Z, Liao X, Tang S, Li N, Hou S
Front Cell Neurosci
. 2022 Jan;
15:774305.
PMID: 34975410
The N6-methyladenosine (m6A) modification is the most abundant posttranscriptional mRNA modification in mammalian cells and is dynamically modulated by a series of "writers," "erasers," and "readers." Studies have shown that...
9.
Zhang C, Liu T, Luo P, Gao L, Liao X, Ma L, et al.
Sci Adv
. 2021 Feb;
7(1).
PMID: 33523835
Acute myeloid leukemia (AML) is a deadly hematological malignancy with frequent disease relapse. The biggest challenge for AML therapy is the lack of methods to target and kill the heterogeneous...
10.
Hou S, Li N, Liao X, Kijlstra A, Yang P
Exp Eye Res
. 2019 Nov;
190:107853.
PMID: 31669406
Uveitis is usually considered as a vision-threatening multiple system intraocular inflammatory disease. Among uveitis, Vogt-Koyanagi-Harada (VKH) disease and Behcet's disease (BD) are common non-infectious uveitis entities. Although the exact pathogenesis...